VIVO Cannabis Inc. VVCIF

RE:Information by Affiliation - Buyout?

[dubiousone]

It does substantiate my feelings about this company. I’m pretty comfortable that my investment is safe in this play, the cash value alone is 1/3 the price, so all else is discounted. albeit the paper loss sucks. It’s rare to see a company with what you’d otherwise believe are good results be taken to the cleaners. I keep buying though bc well... I’m comfortable with putting money into this. The pace of progress of updates are increasing. It’s expected it’d take time for true development and sales to warrant updates and not fluff NRs and this companies never been one to fluff. 

The only time I’ve seen companies be so misspriced is active price suppression for buyout. Or something not on the up and up. It’s rare it stays missvalued for long either way and my instincts say this is of the former variety. 

Meeky wrote: I have been invested with Vivo Cannabis for over two years and have taken a substantial loss on paper, unless I sell. I am affiliated with those indirectly working with Vivo, so I might have a leg up on some, but not enough to know when to sell, because of what I hear on a regular basis. It is not hard to figure out, all the news releases over the last couple of years (all positive) to know that Vivo is going places and this low share price will be a thing of the past real soon!

Reading all these posts on Stockhouse will/could scare you out of your shares and possibly miss a Vivo merger/acquistion like Cronos Group offering 37 million shares of their stock to acquire Vivo's 4% share of the Cannabis market (hint). 

The founder Keneth Clement is a pawn in a game of chess (weak) and will be taken out of the picture real soon. Anything you heard about him is hearsay and nothing more.

Vivo management is focusing on the operations with great success and last week they delivered record results, they have secured a significant share of the recreational market and have a large and growing medical cannabis operation.
It may take time, but the market will finally see the potential value of Vivo Cannabis and we’ll see a better valuation. Unfortunately, I don't think we will be around long enough to see it reach over $5.00 plus a share, let alone Q1.